Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Stephen P. Creekmore"'
Autor:
Thomas A. Waldmann, Mario Roederer, Stephen P. Creekmore, Jason L. Yovandich, Joanna H. Shih, Cody J. Peer, William D. Figg, Jennifer Hsu, Liyanage P. Perera, Michael Petrus, Bonita R. Bryant, Sigrid Dubois, Thomas A. Fleisher, Milos D. Miljkovic, Chyi-Chia Richard Lee, Stefania Pittaluga, E. Lake Potter, Kevin C. Conlon
Supplementary Table S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d1bf1c000cdaa5e45163768f14b90ad
https://doi.org/10.1158/1078-0432.22472925
https://doi.org/10.1158/1078-0432.22472925
Autor:
Thomas A. Waldmann, Mario Roederer, Stephen P. Creekmore, Jason L. Yovandich, Joanna H. Shih, Cody J. Peer, William D. Figg, Jennifer Hsu, Liyanage P. Perera, Michael Petrus, Bonita R. Bryant, Sigrid Dubois, Thomas A. Fleisher, Milos D. Miljkovic, Chyi-Chia Richard Lee, Stefania Pittaluga, E. Lake Potter, Kevin C. Conlon
Supplementary Figure S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd7ee296ed768898d0927feed11daee
https://doi.org/10.1158/1078-0432.22472958
https://doi.org/10.1158/1078-0432.22472958
Autor:
Thomas A. Waldmann, Mario Roederer, Stephen P. Creekmore, Jason L. Yovandich, Joanna H. Shih, Cody J. Peer, William D. Figg, Jennifer Hsu, Liyanage P. Perera, Michael Petrus, Bonita R. Bryant, Sigrid Dubois, Thomas A. Fleisher, Milos D. Miljkovic, Chyi-Chia Richard Lee, Stefania Pittaluga, E. Lake Potter, Kevin C. Conlon
Supplementary Data (Tracking)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3950620d876ff80b11022940ee60e6c
https://doi.org/10.1158/1078-0432.22472937
https://doi.org/10.1158/1078-0432.22472937
Autor:
Thomas A. Waldmann, Mario Roederer, Stephen P. Creekmore, Jason L. Yovandich, Joanna H. Shih, Cody J. Peer, William D. Figg, Jennifer Hsu, Liyanage P. Perera, Michael Petrus, Bonita R. Bryant, Sigrid Dubois, Thomas A. Fleisher, Milos D. Miljkovic, Chyi-Chia Richard Lee, Stefania Pittaluga, E. Lake Potter, Kevin C. Conlon
Purpose:The first-in-human clinical trial with human bolus intravenous infusion IL15 (rhIL15) was limited by treatment-associated toxicity. Here, we report toxicity, immunomodulation, and clinical activity of rhIL15 administered as a 10-day continuou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c59bd9e44049b887a568fab0a909f2
https://doi.org/10.1158/1078-0432.c.6528375
https://doi.org/10.1158/1078-0432.c.6528375
Autor:
Cody J. Peer, Sigrid Dubois, Thomas A. Fleisher, Milos D. Miljkovic, E. Lake Potter, Michael N. Petrus, Thomas A. Waldmann, Bonita R. Bryant, William D. Figg, Kevin C. Conlon, Stefania Pittaluga, Joanna H. Shih, Stephen P. Creekmore, Mario Roederer, Liyanage P. Perera, Chyi-Chia Richard Lee, Jennifer L. Hsu, Jason L. Yovandich
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(16)
Purpose: The first-in-human clinical trial with human bolus intravenous infusion IL15 (rhIL15) was limited by treatment-associated toxicity. Here, we report toxicity, immunomodulation, and clinical activity of rhIL15 administered as a 10-day continuo
Autor:
Manish R. Patel, John A. Thompson, Steven P. Fling, Kevin C. Conlon, Chihiro Morishima, Holbrook E Kohrt, Jeffrey S. Miller, Stephen P. Creekmore, Paul M. Sondel, Thomas A. Waldmann, Heather A. Wakelee, Douglas G. McNeel, Mary L. Disis, Minjun C. Apodaca
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts The Cancer Immunotherapy Trials Network is conducting a Phase I, dose-escalation study of subcutaneous (SQ) rhIL-15 in advanced melanoma, renal cell, non-small cell lung (NSCLC) and squamous cell head and neck carcinoma patients. IL
Autor:
Vinay V. Vyas, George Mitra, W. Gregory Alvord, Octavio A. Quiñones, Gopalan Soman, Hengguang Jiang, Jason L. Yovandich, Thomas A. Waldmann, Stephen P. Creekmore, Steve Giardina, Xiaoyi Yang
Publikováno v:
Journal of Immunological Methods. 348:83-94
A colorimetric cell proliferation assay using soluble tetrazolium salt [(CellTiter 96(R) Aqueous One Solution) cell proliferation reagent, containing the (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner
Autor:
Dominic Esposito, Man-Shiow Jiang, Anthony R. Welch, Zhen Xiao, George Mitra, Jinhui Yuan, Simona Colantonio, Xiaoyi Yang, Trevor Broadt, Stephen P. Creekmore, Earl Nelson, DaRue A. Prieto, Ralph F. Hopkins, Jianwei Zhu
Publikováno v:
International immunopharmacology. 29(2)
Targeted inhibiting insulin-like growth factor 1 is an effective approach for cancer therapy. Insulin-like growth factor binding protein 7 (IGFBP7) is considered as a potential therapeutic protein. However, producing high quality of such non-IgG prot
Autor:
Thelma M. Watson, Elaine S. Jaffe, Barry L. Gause, Craig W. Reynolds, Robin Pennington, Carol B. Kobrin, Lars Sternas, P L Duffey, Dan L. Longo, Floyd A. Benko, Christopher D. Gocke, Maurizio Bendandi, Larry W. Kwak, Stephen P. Creekmore
Publikováno v:
Nature Medicine. 5:1171-1177
Lymphomas express a tumor-specific antigen which can be targeted by cancer vaccination. We evaluated the ability of a new idiotype protein vaccine formulation to eradicate residual t(14;18)+ lymphoma cells in 20 patients in a homogeneous, chemotherap
Autor:
Stephen P. Creekmore, Margaret Beckwith, Daniel W. McVicar, Dan L. Longo, Anna T. Mason, John R. Ortaldo
Publikováno v:
Journal of Leukocyte Biology. 60:533-539
The monoclonal antibody (mAb) R24 is a murine immunoglobulin G3 (IgG3) that reacts with the GD3 disialoganglioside present on melanoma cells as well as a subset of T cells. R24 mAb has induced antitumor responses both alone and in combination with in